Page 1 of Clinical Trials for valsartan, 208 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
To Demonstrate Non-inferiority of Combination of 5 mg Amlodipine/ 80 mg Valsartan to 160 mg Valsartan Alone
Last Updated: September 13, 2011
Condition(s): Hypertension; High Blood Pressure
2
Completed
Efficacy and Safety of Valsartan/Amlodipine in Patients With Mild to Moderate Essential Hypertension
Last Updated: May 18, 2011
Condition(s): Essential Hypertension
3
Completed
Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus
Last Updated: May 3, 2012
Condition(s): Hypertension
4
Completed
Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension.
Last Updated: April 15, 2011
Condition(s): Hypertension
5
Completed
Efficacy/Safety of Valsartan Plus Amlodipine and Valsartan Alone in Patients With Hypertension
Last Updated: April 26, 2011
Condition(s): Hypertension
6
Completed
8 Weeks Study to Evaluate the Efficacy and Safety of Valsartan in Combination With Aliskiren Compared to Valsartan Alone in Patients With Stage 2 Hypertension
Last Updated: March 31, 2011
Condition(s): Stage 2 Hypertension
7
Completed
Low-dose Nifedipine-Valsartan Combination Compared to Up-titrated Valsartan Monotherapy in Essential Hypertension
Last Updated: June 17, 2011
Condition(s): Hypertension
8
Completed
Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 as Compared to Amlodipine/Valsartan 5/40 or to Amlodipine 5 mg Monotherapy in Patients 65 Years of Age and Older With Essential Hypertension
Last Updated: May 4, 2011
Condition(s): Hypertension
9
Completed
Long-term Study of Nateglinide+Valsartan to Prevent or Delay Type II Diabetes Mellitus and Cardiovascular Complications
Last Updated: June 27, 2011
Condition(s): Diabetes Mellitus, Type 2
10
Active, not recruiting
Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease
Last Updated: April 6, 2012
Condition(s): Proteinuric Kidney Disease; Diabetic Nephropathy; Hypertensive Nephrosclerosis; IgA Nephropathy; Focal Segmental Glomerulosclerosis; Glomerulopathy (Obesity-associated); Glomerulonephritis, Membranous
11
Completed
Kanagawa Valsartan Trial (KVT): Effects of Valsartan on Renal and Cardiovascular Disease
Last Updated: March 20, 2009
Condition(s): Chronic Kidney Disease; Hypertension
12
Completed
A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Valsartan in Healthy Volunteers
Last Updated: May 26, 2010
Condition(s): Healthy; Pharmacokinetics of Valsartan
13
Completed
To Compare the Blood Level of Marketed Japanese Valsartan Tablet Formulation vs Global Valsartan Tablet Formulation in Healthy Volunteers
Last Updated: June 21, 2007
Condition(s): Healthy
14
Completed
Cardioprotective Benefits of Carvedilol-CR or Valsartan Added to Lisinopril
Last Updated: June 30, 2010
Condition(s): Hypertension
15
Completed
Long Term Study of Valsartan and Amlodipine in Patients With Essential Hypertension (Extension to Study CVAA489A1301)
Last Updated: May 6, 2012
Condition(s): Hypertension
16
Completed
A Safety and Tolerability Study of the Combination of Aliskiren/Valsartan in Patients With High Blood Pressure, Followed by Long-term Safety and Tolerability of Aliskiren, Valsartan and Hydrochlorothiazide.
Last Updated: April 7, 2011
Condition(s): Hypertension
17
Completed
Comparison of the Antihypertensive Efficacy of Valsartan and Enalapril After Missing One Dose
Last Updated: January 2, 2009
Condition(s): Hypertension
18
Completed
Bioavailability of Aliskiren and Valsartan Combined as a Single Tablet vs. the Same Medications Given Separately to Healthy Subjects.
Last Updated: June 21, 2007
Condition(s): Healthy
19
Completed
Bioavailability of Aliskiren and Valsartan as a Single Tablet vs. the Same Doses of the Two Drugs Given Separately to Healthy Subjects.
Last Updated: June 21, 2007
Condition(s): Healthy
20
Active, not recruiting
A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy
Last Updated: January 6, 2012
Condition(s): Glomerulonephritis; IGA Nephropathy

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=valsartan

Page 1 of Clinical Trials for valsartan, 208 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About